Evidence map›Paper›PMID 37833902›Full record

ArticleInternational journal of molecular sciences2023

A Network Comprised of miR-15b and miR-29a Is Involved in Vascular Endothelial Growth Factor Pathway Regulation in Thymus Adipose Tissue from Elderly Ischemic Cardiomyopathy Subjects.

Adriana Mariel Gentile, Said Lhamyani, María Mengual Mesa, Francisco Javier Pavón-Morón, John R Pearson, Julián Salas, Mercedes Clemente-Postigo, Lucía Pérez Costillas, Gabriel Olveira Fuster, Rajaa El Bekay Rizky

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Adriana Mariel GentileInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Malaga, Spain.ORCID 0000-0002-2296-9117
Said LhamyaniInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Malaga, Spain.ORCID 0000-0002-9830-9772
María Mengual MesaInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Malaga, Spain.
Francisco Javier Pavón-MorónInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Malaga, Spain.ORCID 0000-0002-5256-8904
John R PearsonBiomedicine Institute of Seville (IBiS), 41013 Seville, Spain.
Julián SalasDepartment of Cardiovascular Surgery, University Regional Hospital of Malaga, 29009 Malaga, Spain.
Mercedes Clemente-PostigoInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Malaga, Spain.
Lucía Pérez CostillasResearch Unit, International Institute for Innovation and Care in Neurodevelopment and Language, Department of Psychiatry and Physiotherapy, Faculty of Medicine, University of Malaga, 29010 Malaga, Spain.
Gabriel Olveira FusterInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Malaga, Spain.ORCID 0000-0002-7646-2899
Rajaa El Bekay RizkyInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29580 Malaga, Spain.ORCID 0000-0003-3332-3431
Hospital Regional Universitario de Málaga · ESInstituto de Salud Carlos III · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESInstituto de Biomedicina de Sevilla · ESUniversidad de Málaga · ES

Funding

Consejería de Transformación Económica, Industria, Conocimiento y Universidades-Junta de Andalucía and ERDF-EU PI20-01274ISCIII and the European Regional Development Fund (ERDF-EU) PI21/01924, PI18/00785
6 · The paper itself

Abstract

As the human thymus ages, it undergoes a transformation into adipose tissue known as TAT. Interestingly, in previous research, we observed elevated levels of vascular endothelial growth factor A (VEGFA) in TAT from patients with ischemic cardiomyopathy (IC), particularly in those over 70 years old. Moreover, in contrast to subcutaneous adipose tissue (SAT), TAT in elderly individuals exhibits enhanced angiogenic properties and the ability to stimulate tube formation. This makes TAT a promising candidate for angiogenic therapies and the regeneration of ischemic tissues following coronary surgery. MicroRNAs (miRNAs) have emerged as attractive therapeutic targets, especially those that regulate angiogenic processes. The study's purpose is to determine the miRNA network associated with both the VEGFA pathway regulation and the enrichment of age-linked angiogenesis in the TAT. RT-PCR was used to analyze angiogenic miRNAs and the expression levels of their predicted target genes in both TAT and SAT from elderly and middle-aged patients treated with coronary artery bypass graft surgery. miRTargetLink Human was used to search for miRNAs and their target genes. PANTHER was used to annotate the biological processes of the predicted targets. The expression of miR-15b-5p and miR-29a-3p was significantly upregulated in the TAT of elderly compared with middle-aged patients. Interestingly,

Indexed as

CardiomyopathiesMicroRNAsMyocardial IschemiaAdipose TissueAgedHumansMiddle AgedVascular Endothelial Growth Factor AMicroRNAsMIRN15 microRNA, humanMIRN29a microRNA, humanVascular Endothelial Growth Factor AagingangiogenesiselderlyischemiamicroRNAmyocardial infarctionsubcutaneous adipose tissuethymus adipose tissue

Identifiers

PMID37833902
PMCPMC10572810
OpenAlexW4386996801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.